

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cell size (GO:0045793) | 8.66512412 |
| 2 | arginine catabolic process (GO:0006527) | 8.25421921 |
| 3 | diaphragm development (GO:0060539) | 8.08670450 |
| 4 | exogenous drug catabolic process (GO:0042738) | 7.44295740 |
| 5 | skeletal muscle organ development (GO:0060538) | 7.37277533 |
| 6 | negative regulation of neurotransmitter transport (GO:0051589) | 7.24333323 |
| 7 | arginine metabolic process (GO:0006525) | 6.97336091 |
| 8 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 6.44477861 |
| 9 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 6.21189382 |
| 10 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.93304388 |
| 11 | cellular protein complex localization (GO:0034629) | 5.83048590 |
| 12 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 5.76657754 |
| 13 | response to lipoprotein particle (GO:0055094) | 5.75079685 |
| 14 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 5.74137590 |
| 15 | pyrimidine nucleoside salvage (GO:0043097) | 5.69398747 |
| 16 | pyrimidine-containing compound salvage (GO:0008655) | 5.69398747 |
| 17 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 5.65894139 |
| 18 | negative regulation of vascular permeability (GO:0043116) | 5.62624750 |
| 19 | negative regulation of potassium ion transport (GO:0043267) | 5.26489823 |
| 20 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.26487237 |
| 21 | regulation of neurotransmitter uptake (GO:0051580) | 5.25547113 |
| 22 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.21520419 |
| 23 | UMP biosynthetic process (GO:0006222) | 5.20461266 |
| 24 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 5.20461266 |
| 25 | UMP metabolic process (GO:0046049) | 5.20461266 |
| 26 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 5.20461266 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 5.11316836 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.11316836 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 4.94319476 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.94319476 |
| 31 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 4.78766379 |
| 32 | regulation of guanylate cyclase activity (GO:0031282) | 4.77928671 |
| 33 | cysteine metabolic process (GO:0006534) | 4.77880021 |
| 34 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 4.46067862 |
| 35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.42121491 |
| 36 | intestinal cholesterol absorption (GO:0030299) | 4.36380823 |
| 37 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 4.28776179 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 4.21474920 |
| 39 | lateral sprouting from an epithelium (GO:0060601) | 4.09700951 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.04073761 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.97917474 |
| 42 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.96359848 |
| 43 | regulation of stem cell maintenance (GO:2000036) | 3.96250602 |
| 44 | nitric oxide mediated signal transduction (GO:0007263) | 3.93502908 |
| 45 | neurotransmitter biosynthetic process (GO:0042136) | 3.91202501 |
| 46 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.90455420 |
| 47 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.90455420 |
| 48 | nucleotide salvage (GO:0043173) | 3.88337756 |
| 49 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.85130342 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 3.84495350 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 3.80568942 |
| 52 | nitric oxide biosynthetic process (GO:0006809) | 3.79753395 |
| 53 | protein heterotrimerization (GO:0070208) | 3.78656673 |
| 54 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.73876021 |
| 55 | positive regulation of catecholamine secretion (GO:0033605) | 3.73875767 |
| 56 | regulation of cilium movement (GO:0003352) | 3.73176770 |
| 57 | lysine catabolic process (GO:0006554) | 3.72102868 |
| 58 | lysine metabolic process (GO:0006553) | 3.72102868 |
| 59 | negative regulation of protein kinase B signaling (GO:0051898) | 3.70147312 |
| 60 | glyoxylate metabolic process (GO:0046487) | 3.68776150 |
| 61 | alpha-linolenic acid metabolic process (GO:0036109) | 3.68660904 |
| 62 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.68629097 |
| 63 | nucleoside salvage (GO:0043174) | 3.66969092 |
| 64 | histone H3-K4 methylation (GO:0051568) | 3.65226455 |
| 65 | bile acid biosynthetic process (GO:0006699) | 3.61838162 |
| 66 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.60415194 |
| 67 | determination of left/right symmetry (GO:0007368) | 3.60382245 |
| 68 | protein complex localization (GO:0031503) | 3.58431235 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.57328375 |
| 70 | nerve growth factor signaling pathway (GO:0038180) | 3.56279565 |
| 71 | negative regulation of macrophage differentiation (GO:0045650) | 3.54250347 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 3.54095432 |
| 73 | regulation of mitochondrial translation (GO:0070129) | 3.53848810 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.51063749 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 3.45994341 |
| 76 | regulation of cilium assembly (GO:1902017) | 3.45274496 |
| 77 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.45133001 |
| 78 | determination of bilateral symmetry (GO:0009855) | 3.44257917 |
| 79 | protein carboxylation (GO:0018214) | 3.43604903 |
| 80 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.43604903 |
| 81 | respiratory chain complex IV assembly (GO:0008535) | 3.42438843 |
| 82 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.40356623 |
| 83 | activation of MAPKKK activity (GO:0000185) | 3.39345855 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.39171106 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.39171106 |
| 86 | tryptophan catabolic process (GO:0006569) | 3.39171106 |
| 87 | positive regulation of receptor biosynthetic process (GO:0010870) | 3.36533516 |
| 88 | specification of symmetry (GO:0009799) | 3.36272219 |
| 89 | kynurenine metabolic process (GO:0070189) | 3.35365193 |
| 90 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.34495380 |
| 91 | axonemal dynein complex assembly (GO:0070286) | 3.31772729 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.30240419 |
| 93 | myoblast fusion (GO:0007520) | 3.30179262 |
| 94 | epithelial cilium movement (GO:0003351) | 3.29269116 |
| 95 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.28569630 |
| 96 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.28141686 |
| 97 | tryptophan metabolic process (GO:0006568) | 3.27996711 |
| 98 | short-chain fatty acid metabolic process (GO:0046459) | 3.26544055 |
| 99 | glutamate metabolic process (GO:0006536) | 3.25856558 |
| 100 | coenzyme catabolic process (GO:0009109) | 3.24824278 |
| 101 | chromatin silencing (GO:0006342) | 3.23655102 |
| 102 | oogenesis (GO:0048477) | 3.23195692 |
| 103 | serine family amino acid catabolic process (GO:0009071) | 3.22031014 |
| 104 | peptidyl-cysteine modification (GO:0018198) | 3.21098556 |
| 105 | regulation of cGMP biosynthetic process (GO:0030826) | 3.19484404 |
| 106 | protein retention in ER lumen (GO:0006621) | 3.19159595 |
| 107 | regulation of mRNA catabolic process (GO:0061013) | 3.17484084 |
| 108 | axonal fasciculation (GO:0007413) | 3.17230007 |
| 109 | regulation of fibrinolysis (GO:0051917) | 3.15254849 |
| 110 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.14858369 |
| 111 | negative regulation of granulocyte differentiation (GO:0030853) | 3.14837827 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 3.14284022 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13284987 |
| 114 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12182903 |
| 115 | cellular ketone body metabolic process (GO:0046950) | 3.11572994 |
| 116 | alpha-amino acid catabolic process (GO:1901606) | 3.10362006 |
| 117 | establishment of tissue polarity (GO:0007164) | 3.09988973 |
| 118 | establishment of planar polarity (GO:0001736) | 3.09988973 |
| 119 | aromatic amino acid family metabolic process (GO:0009072) | 3.08743425 |
| 120 | CTP biosynthetic process (GO:0006241) | 3.07266715 |
| 121 | CTP metabolic process (GO:0046036) | 3.07266715 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 3.05567909 |
| 123 | exocrine pancreas development (GO:0031017) | 3.05275661 |
| 124 | regulation of protein activation cascade (GO:2000257) | 3.05265994 |
| 125 | reverse cholesterol transport (GO:0043691) | 3.02552819 |
| 126 | positive regulation of mRNA catabolic process (GO:0061014) | 2.99032060 |
| 127 | bile acid metabolic process (GO:0008206) | 2.97893547 |
| 128 | transcytosis (GO:0045056) | 2.97771374 |
| 129 | carnitine metabolic process (GO:0009437) | 2.97145346 |
| 130 | sodium-independent organic anion transport (GO:0043252) | 2.97004727 |
| 131 | regulation of oxidative phosphorylation (GO:0002082) | 2.96620349 |
| 132 | tyrosine metabolic process (GO:0006570) | 2.95746388 |
| 133 | regulation of protein deacetylation (GO:0090311) | 2.94391392 |
| 134 | positive regulation of cGMP metabolic process (GO:0030825) | 2.94078258 |
| 135 | cellular glucuronidation (GO:0052695) | 2.93171658 |
| 136 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.92999352 |
| 137 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.92260927 |
| 138 | cilium movement (GO:0003341) | 2.92103824 |
| 139 | regulation of complement activation (GO:0030449) | 2.91385850 |
| 140 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.90958438 |
| 141 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.90687700 |
| 142 | urea cycle (GO:0000050) | 2.89781973 |
| 143 | urea metabolic process (GO:0019627) | 2.89781973 |
| 144 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.89732151 |
| 145 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.88269448 |
| 146 | complement activation, alternative pathway (GO:0006957) | 2.86765270 |
| 147 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84382343 |
| 148 | protein-lipid complex remodeling (GO:0034368) | 2.84382343 |
| 149 | macromolecular complex remodeling (GO:0034367) | 2.84382343 |
| 150 | glycerophospholipid catabolic process (GO:0046475) | 2.82859835 |
| 151 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.81793489 |
| 152 | serine family amino acid metabolic process (GO:0009069) | 2.78496176 |
| 153 | dicarboxylic acid catabolic process (GO:0043649) | 2.76176114 |
| 154 | regulation of cholesterol homeostasis (GO:2000188) | 2.74348000 |
| 155 | glucuronate metabolic process (GO:0019585) | 2.74058868 |
| 156 | uronic acid metabolic process (GO:0006063) | 2.74058868 |
| 157 | purine nucleotide transport (GO:0015865) | 2.72147710 |
| 158 | ethanol oxidation (GO:0006069) | 2.71152736 |
| 159 | drug transmembrane transport (GO:0006855) | 2.71002856 |
| 160 | ketone body metabolic process (GO:1902224) | 2.70756874 |
| 161 | epoxygenase P450 pathway (GO:0019373) | 2.70187231 |
| 162 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.68890355 |
| 163 | nitrogen cycle metabolic process (GO:0071941) | 2.67595232 |
| 164 | 4-hydroxyproline metabolic process (GO:0019471) | 2.66865815 |
| 165 | triglyceride homeostasis (GO:0070328) | 2.64852626 |
| 166 | acylglycerol homeostasis (GO:0055090) | 2.64852626 |
| 167 | gap junction assembly (GO:0016264) | 2.61976047 |
| 168 | drug catabolic process (GO:0042737) | 2.61644826 |
| 169 | cholesterol catabolic process (GO:0006707) | 2.61199034 |
| 170 | sterol catabolic process (GO:0016127) | 2.61199034 |
| 171 | organic acid catabolic process (GO:0016054) | 2.60967994 |
| 172 | carboxylic acid catabolic process (GO:0046395) | 2.60967994 |
| 173 | fibrinolysis (GO:0042730) | 2.57437763 |
| 174 | lipoprotein metabolic process (GO:0042157) | 2.55813747 |
| 175 | positive regulation of fatty acid oxidation (GO:0046321) | 2.55509802 |
| 176 | low-density lipoprotein particle remodeling (GO:0034374) | 2.55245877 |
| 177 | regulation of plasminogen activation (GO:0010755) | 2.54987504 |
| 178 | lipid oxidation (GO:0034440) | 2.53796456 |
| 179 | regulation of phospholipase A2 activity (GO:0032429) | 2.52602853 |
| 180 | benzene-containing compound metabolic process (GO:0042537) | 2.51162150 |
| 181 | negative regulation of sterol transport (GO:0032372) | 2.50869748 |
| 182 | negative regulation of cholesterol transport (GO:0032375) | 2.50869748 |
| 183 | fatty acid oxidation (GO:0019395) | 2.49353708 |
| 184 | indolalkylamine metabolic process (GO:0006586) | 2.48565319 |
| 185 | monocarboxylic acid catabolic process (GO:0072329) | 2.47881315 |
| 186 | 2-oxoglutarate metabolic process (GO:0006103) | 2.46220169 |
| 187 | COPI coating of Golgi vesicle (GO:0048205) | 2.45667840 |
| 188 | Golgi transport vesicle coating (GO:0048200) | 2.45667840 |
| 189 | valine metabolic process (GO:0006573) | 2.44951909 |
| 190 | intestinal absorption (GO:0050892) | 2.44777280 |
| 191 | adenine nucleotide transport (GO:0051503) | 2.43624938 |
| 192 | purine ribonucleotide transport (GO:0015868) | 2.43560696 |
| 193 | urate metabolic process (GO:0046415) | 2.43546781 |
| 194 | positive regulation of lipid catabolic process (GO:0050996) | 2.43249146 |
| 195 | fatty acid beta-oxidation (GO:0006635) | 2.42722551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.59443726 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21111295 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59686326 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.47283773 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.83933700 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.71405185 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.45827875 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.33574907 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27444200 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27077680 |
| 11 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.24896824 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15928135 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14581586 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95508493 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93708383 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90870002 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74328994 |
| 18 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.72557286 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69547592 |
| 20 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67927870 |
| 21 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67927870 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61658094 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56692340 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55995423 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55552893 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52684729 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49515476 |
| 28 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.49042617 |
| 29 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47775304 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47545228 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46535320 |
| 32 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.44692975 |
| 33 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.43119227 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42283994 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41744401 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39504796 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39477582 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39463430 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39030421 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38351434 |
| 41 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38303211 |
| 42 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37431240 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37356333 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35905373 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35789500 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34384691 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33951424 |
| 48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33951424 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33433689 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33190367 |
| 51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32873645 |
| 52 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.30677196 |
| 53 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30513543 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30372033 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29888542 |
| 56 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29432025 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27588130 |
| 58 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.27219505 |
| 59 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.26259745 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.24955224 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24928864 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24637221 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23958156 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23441263 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.23189210 |
| 66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20324058 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19459458 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19154831 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17367228 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17223470 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16166827 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15460290 |
| 73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15223385 |
| 74 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14923118 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12572020 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.12395042 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12287436 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11877758 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11625719 |
| 80 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11486359 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11393463 |
| 82 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11239888 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10790982 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10767986 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10393036 |
| 86 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10130847 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09990607 |
| 88 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09271917 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08795673 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07675760 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05264402 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04154238 |
| 93 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03626243 |
| 94 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02614494 |
| 95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01929548 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01379678 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00655878 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00470565 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99483491 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.99193277 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98826685 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98431891 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98164728 |
| 104 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98061598 |
| 105 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97744921 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97307269 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97077604 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96580790 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96316535 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95774863 |
| 111 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95584868 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95535808 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93619117 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93126750 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 0.92946945 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92594302 |
| 117 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.91405165 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91340086 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91287222 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90670341 |
| 121 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90535518 |
| 122 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89420308 |
| 123 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88377122 |
| 124 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87887925 |
| 125 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.87765557 |
| 126 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87116821 |
| 127 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86967901 |
| 128 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86843033 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86740222 |
| 130 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86719903 |
| 131 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86719903 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86308504 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86033342 |
| 134 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85532433 |
| 135 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85034638 |
| 136 | AR_19668381_ChIP-Seq_PC3_Human | 0.84464733 |
| 137 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82429645 |
| 138 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81936937 |
| 139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81894155 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81490978 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80374089 |
| 142 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80224218 |
| 143 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79816352 |
| 144 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79311738 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78849222 |
| 146 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75500048 |
| 147 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.74595397 |
| 148 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.74533352 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74126315 |
| 150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.73631738 |
| 151 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72876320 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72714249 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72714249 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72555681 |
| 155 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71544831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 7.25066462 |
| 2 | MP0003646_muscle_fatigue | 7.15832041 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.43878069 |
| 4 | MP0002234_abnormal_pharynx_morphology | 5.27403369 |
| 5 | MP0005365_abnormal_bile_salt | 4.60564095 |
| 6 | MP0005360_urolithiasis | 4.44584892 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 4.30463698 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 3.91925383 |
| 9 | MP0005083_abnormal_biliary_tract | 3.88785140 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.49373288 |
| 11 | MP0003252_abnormal_bile_duct | 3.21839845 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.84355131 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.79564608 |
| 14 | MP0003011_delayed_dark_adaptation | 2.63490170 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.58551099 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.50031103 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.38546953 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.33859476 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 2.33710250 |
| 20 | MP0003868_abnormal_feces_composition | 2.25488869 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.19199615 |
| 22 | MP0005220_abnormal_exocrine_pancreas | 2.17678246 |
| 23 | MP0003718_maternal_effect | 2.09337578 |
| 24 | MP0003195_calcinosis | 2.09316784 |
| 25 | MP0005332_abnormal_amino_acid | 2.06411494 |
| 26 | MP0003880_abnormal_central_pattern | 1.99827143 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.93889159 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.88746641 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.82599987 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.76281387 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.73440424 |
| 32 | MP0002233_abnormal_nose_morphology | 1.66935700 |
| 33 | MP0006082_CNS_inflammation | 1.61871228 |
| 34 | MP0008872_abnormal_physiological_respon | 1.60779619 |
| 35 | MP0001919_abnormal_reproductive_system | 1.54301994 |
| 36 | MP0000467_abnormal_esophagus_morphology | 1.53870527 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.49469113 |
| 38 | MP0003279_aneurysm | 1.48242471 |
| 39 | MP0001984_abnormal_olfaction | 1.43447445 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.42993926 |
| 41 | MP0009745_abnormal_behavioral_response | 1.40001661 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.39784570 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.39109077 |
| 44 | MP0004858_abnormal_nervous_system | 1.36566280 |
| 45 | MP0004036_abnormal_muscle_relaxation | 1.33060511 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.27717623 |
| 47 | MP0001542_abnormal_bone_strength | 1.27413939 |
| 48 | MP0009840_abnormal_foam_cell | 1.24042753 |
| 49 | MP0004133_heterotaxia | 1.23305976 |
| 50 | MP0003123_paternal_imprinting | 1.23290429 |
| 51 | MP0005275_abnormal_skin_tensile | 1.23266479 |
| 52 | MP0002928_abnormal_bile_duct | 1.23118338 |
| 53 | MP0002896_abnormal_bone_mineralization | 1.22168112 |
| 54 | MP0002272_abnormal_nervous_system | 1.21636184 |
| 55 | MP0009053_abnormal_anal_canal | 1.20830354 |
| 56 | MP0000955_abnormal_spinal_cord | 1.19222717 |
| 57 | MP0001440_abnormal_grooming_behavior | 1.18665871 |
| 58 | MP0005503_abnormal_tendon_morphology | 1.18143376 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 1.14512331 |
| 60 | MP0006138_congestive_heart_failure | 1.11778727 |
| 61 | MP0002064_seizures | 1.11431819 |
| 62 | MP0005394_taste/olfaction_phenotype | 1.11149802 |
| 63 | MP0005499_abnormal_olfactory_system | 1.11149802 |
| 64 | MP0004272_abnormal_basement_membrane | 1.10330516 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 1.09703656 |
| 66 | MP0001958_emphysema | 1.09333905 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.08512575 |
| 68 | MP0000733_abnormal_muscle_development | 1.06390983 |
| 69 | MP0000609_abnormal_liver_physiology | 1.04880707 |
| 70 | MP0004484_altered_response_of | 1.04562728 |
| 71 | MP0003283_abnormal_digestive_organ | 1.02392904 |
| 72 | MP0000013_abnormal_adipose_tissue | 1.01812698 |
| 73 | MP0002063_abnormal_learning/memory/cond | 1.01686399 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.01678770 |
| 75 | MP0004885_abnormal_endolymph | 1.00239024 |
| 76 | MP0010307_abnormal_tumor_latency | 0.99667417 |
| 77 | MP0002090_abnormal_vision | 0.99208391 |
| 78 | MP0005389_reproductive_system_phenotype | 0.97101198 |
| 79 | MP0002009_preneoplasia | 0.97034084 |
| 80 | MP0001944_abnormal_pancreas_morphology | 0.96266327 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.95152368 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.94125042 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.93881527 |
| 84 | MP0003635_abnormal_synaptic_transmissio | 0.93417178 |
| 85 | MP0003633_abnormal_nervous_system | 0.93044683 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.92989790 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.92656535 |
| 88 | MP0004043_abnormal_pH_regulation | 0.92385958 |
| 89 | MP0002168_other_aberrant_phenotype | 0.92082306 |
| 90 | MP0005253_abnormal_eye_physiology | 0.91578126 |
| 91 | MP0002127_abnormal_cardiovascular_syste | 0.89537180 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.88860072 |
| 93 | MP0001764_abnormal_homeostasis | 0.88104070 |
| 94 | MP0000537_abnormal_urethra_morphology | 0.87901212 |
| 95 | MP0002116_abnormal_craniofacial_bone | 0.87572969 |
| 96 | MP0002109_abnormal_limb_morphology | 0.86733129 |
| 97 | MP0002572_abnormal_emotion/affect_behav | 0.84347816 |
| 98 | MP0003942_abnormal_urinary_system | 0.84338319 |
| 99 | MP0003690_abnormal_glial_cell | 0.83841690 |
| 100 | MP0005670_abnormal_white_adipose | 0.83615593 |
| 101 | MP0009046_muscle_twitch | 0.83066623 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.82447588 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81892225 |
| 104 | MP0003959_abnormal_lean_body | 0.81509884 |
| 105 | MP0000383_abnormal_hair_follicle | 0.80852432 |
| 106 | MP0001756_abnormal_urination | 0.79987443 |
| 107 | MP0004233_abnormal_muscle_weight | 0.78369373 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.78246322 |
| 109 | MP0005408_hypopigmentation | 0.76733846 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.76337575 |
| 111 | MP0003631_nervous_system_phenotype | 0.76275970 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.76131858 |
| 113 | MP0000778_abnormal_nervous_system | 0.76131107 |
| 114 | MP0002184_abnormal_innervation | 0.76068416 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.75970795 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.75695846 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.75114467 |
| 118 | MP0005195_abnormal_posterior_eye | 0.74553583 |
| 119 | MP0003119_abnormal_digestive_system | 0.73713899 |
| 120 | MP0003329_amyloid_beta_deposits | 0.73108837 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.72989154 |
| 122 | MP0001324_abnormal_eye_pigmentation | 0.70992182 |
| 123 | MP0001970_abnormal_pain_threshold | 0.70373257 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.68550319 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.68532121 |
| 126 | MP0008004_abnormal_stomach_pH | 0.68221683 |
| 127 | MP0004130_abnormal_muscle_cell | 0.68172409 |
| 128 | MP0005187_abnormal_penis_morphology | 0.67972576 |
| 129 | MP0001177_atelectasis | 0.67454006 |
| 130 | MP0004859_abnormal_synaptic_plasticity | 0.66300592 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.66288014 |
| 132 | MP0000432_abnormal_head_morphology | 0.65054381 |
| 133 | MP0005448_abnormal_energy_balance | 0.64627248 |
| 134 | MP0006072_abnormal_retinal_apoptosis | 0.64271587 |
| 135 | MP0001664_abnormal_digestion | 0.64238786 |
| 136 | MP0005535_abnormal_body_temperature | 0.63851615 |
| 137 | MP0002734_abnormal_mechanical_nocicepti | 0.63522561 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.63347371 |
| 139 | MP0001486_abnormal_startle_reflex | 0.61113137 |
| 140 | MP0003879_abnormal_hair_cell | 0.60815840 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.60580040 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.60214427 |
| 143 | MP0001299_abnormal_eye_distance/ | 0.60201511 |
| 144 | MP0005395_other_phenotype | 0.59936994 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.59508121 |
| 146 | MP0003045_fibrosis | 0.58670260 |
| 147 | MP0005636_abnormal_mineral_homeostasis | 0.57135665 |
| 148 | MP0003634_abnormal_glial_cell | 0.56062377 |
| 149 | MP0002067_abnormal_sensory_capabilities | 0.54696384 |
| 150 | MP0005508_abnormal_skeleton_morphology | 0.54337224 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.54069938 |
| 152 | MP0004883_abnormal_blood_vessel | 0.53954403 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.53925870 |
| 154 | MP0004270_analgesia | 0.53898487 |
| 155 | MP0002822_catalepsy | 0.53516614 |
| 156 | MP0000598_abnormal_liver_morphology | 0.53409966 |
| 157 | MP0002735_abnormal_chemical_nociception | 0.52626837 |
| 158 | MP0002877_abnormal_melanocyte_morpholog | 0.52476201 |
| 159 | MP0005197_abnormal_uvea_morphology | 0.52390197 |
| 160 | MP0000767_abnormal_smooth_muscle | 0.51802648 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.50315187 |
| 162 | MP0002229_neurodegeneration | 0.49954173 |
| 163 | MP0003953_abnormal_hormone_level | 0.49729990 |
| 164 | MP0002882_abnormal_neuron_morphology | 0.49044424 |
| 165 | MP0001485_abnormal_pinna_reflex | 0.48821166 |
| 166 | MP0009764_decreased_sensitivity_to | 0.47876354 |
| 167 | MP0001765_abnormal_ion_homeostasis | 0.47297488 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.46719864 |
| 169 | MP0008961_abnormal_basal_metabolism | 0.46441008 |
| 170 | MP0005334_abnormal_fat_pad | 0.46325133 |
| 171 | MP0002932_abnormal_joint_morphology | 0.46304637 |
| 172 | MP0006276_abnormal_autonomic_nervous | 0.46233409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lip pit (HP:0100267) | 7.83924191 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 6.81029348 |
| 3 | Anal stenosis (HP:0002025) | 6.72481572 |
| 4 | Sparse lateral eyebrow (HP:0005338) | 6.71408311 |
| 5 | Depressed nasal tip (HP:0000437) | 6.02130732 |
| 6 | Intestinal fistula (HP:0100819) | 5.69342402 |
| 7 | Abnormality of the fingertips (HP:0001211) | 5.23112610 |
| 8 | Ureteral stenosis (HP:0000071) | 4.83167882 |
| 9 | Short 5th finger (HP:0009237) | 4.67164550 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.57800542 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.48598700 |
| 12 | Ureteral obstruction (HP:0006000) | 4.45841565 |
| 13 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 4.36623531 |
| 14 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.28835914 |
| 15 | Popliteal pterygium (HP:0009756) | 4.27701209 |
| 16 | Lower limb hyperreflexia (HP:0002395) | 4.16998393 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 4.13584914 |
| 18 | Xanthomatosis (HP:0000991) | 3.96043037 |
| 19 | Ectopic kidney (HP:0000086) | 3.85687774 |
| 20 | Preauricular pit (HP:0004467) | 3.68996980 |
| 21 | Periauricular skin pits (HP:0100277) | 3.68996980 |
| 22 | Gout (HP:0001997) | 3.60557413 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.36408829 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 3.33720574 |
| 25 | Chorioretinal atrophy (HP:0000533) | 3.32675712 |
| 26 | Posterior subcapsular cataract (HP:0007787) | 3.25402381 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.23513934 |
| 28 | Hyperglycinemia (HP:0002154) | 3.16545569 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.14013101 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.14013101 |
| 31 | Atonic seizures (HP:0010819) | 3.11622375 |
| 32 | Ketosis (HP:0001946) | 3.08054066 |
| 33 | Ketoacidosis (HP:0001993) | 3.05805465 |
| 34 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.04356212 |
| 35 | Vertebral hypoplasia (HP:0008417) | 3.04356212 |
| 36 | Hypolipoproteinemia (HP:0010981) | 2.95507402 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.95139326 |
| 38 | Aplasia involving bones of the extremities (HP:0009825) | 2.93385443 |
| 39 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.93385443 |
| 40 | Aplasia of the phalanges of the hand (HP:0009802) | 2.93385443 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.92769936 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92769936 |
| 43 | Pigmentary retinal degeneration (HP:0001146) | 2.91209345 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.90151057 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.89610469 |
| 46 | Fat malabsorption (HP:0002630) | 2.83679892 |
| 47 | Abnormal drinking behavior (HP:0030082) | 2.82728825 |
| 48 | Polydipsia (HP:0001959) | 2.82728825 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.81837821 |
| 50 | Complement deficiency (HP:0004431) | 2.77961571 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77944884 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 2.77944884 |
| 53 | Chronic bronchitis (HP:0004469) | 2.76192154 |
| 54 | Tubular atrophy (HP:0000092) | 2.75985515 |
| 55 | Hyperglycinuria (HP:0003108) | 2.74917253 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.74808535 |
| 57 | Pancreatic cysts (HP:0001737) | 2.74637760 |
| 58 | Hyperammonemia (HP:0001987) | 2.74228564 |
| 59 | Central scotoma (HP:0000603) | 2.71264130 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.71209551 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70930534 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66830271 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66830271 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66830271 |
| 65 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.64073952 |
| 66 | Pheochromocytoma (HP:0002666) | 2.63520165 |
| 67 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.63055890 |
| 68 | Absent eyebrow (HP:0002223) | 2.60165804 |
| 69 | Facial cleft (HP:0002006) | 2.58060885 |
| 70 | Abnormality of macular pigmentation (HP:0008002) | 2.54048923 |
| 71 | Dyschromatopsia (HP:0007641) | 2.53434684 |
| 72 | Long palpebral fissure (HP:0000637) | 2.53124061 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.50038561 |
| 74 | Preaxial foot polydactyly (HP:0001841) | 2.49848417 |
| 75 | Skin pits (HP:0100276) | 2.49277185 |
| 76 | Natal tooth (HP:0000695) | 2.49088483 |
| 77 | Premature rupture of membranes (HP:0001788) | 2.48659136 |
| 78 | Rhinitis (HP:0012384) | 2.47821247 |
| 79 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.47519899 |
| 80 | Wide intermamillary distance (HP:0006610) | 2.46641068 |
| 81 | Hypoplastic labia majora (HP:0000059) | 2.46166366 |
| 82 | Ectropion (HP:0000656) | 2.44670638 |
| 83 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42444777 |
| 84 | Mask-like facies (HP:0000298) | 2.39749522 |
| 85 | Vascular calcification (HP:0004934) | 2.39460930 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.37973096 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.36462022 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.36032858 |
| 89 | Frequent falls (HP:0002359) | 2.35683478 |
| 90 | Abnormality of the periventricular white matter (HP:0002518) | 2.34749742 |
| 91 | Congenital stationary night blindness (HP:0007642) | 2.33543638 |
| 92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32716288 |
| 93 | Recurrent otitis media (HP:0000403) | 2.32404305 |
| 94 | Self-mutilation (HP:0000742) | 2.29574610 |
| 95 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.29045969 |
| 96 | Epidermoid cyst (HP:0200040) | 2.27206471 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 2.26667015 |
| 98 | Neuroendocrine neoplasm (HP:0100634) | 2.26380581 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.25822144 |
| 100 | Hypercholesterolemia (HP:0003124) | 2.24712550 |
| 101 | Steatorrhea (HP:0002570) | 2.23478172 |
| 102 | Abnormality of the labia majora (HP:0012881) | 2.22863642 |
| 103 | Absent eyelashes (HP:0000561) | 2.22552014 |
| 104 | Confusion (HP:0001289) | 2.21328257 |
| 105 | Non-midline cleft lip (HP:0100335) | 2.21280876 |
| 106 | Blue irides (HP:0000635) | 2.20631698 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18981519 |
| 108 | Hypoglycemic seizures (HP:0002173) | 2.13452072 |
| 109 | Narrow palate (HP:0000189) | 2.11872909 |
| 110 | Hyperuricemia (HP:0002149) | 2.11634233 |
| 111 | Increased purine levels (HP:0004368) | 2.11634233 |
| 112 | Scotoma (HP:0000575) | 2.11489039 |
| 113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.10781473 |
| 114 | Back pain (HP:0003418) | 2.08981355 |
| 115 | Absence seizures (HP:0002121) | 2.07564074 |
| 116 | Broad hallux (HP:0010055) | 2.06925427 |
| 117 | Polyuria (HP:0000103) | 2.06684814 |
| 118 | Fibular aplasia (HP:0002990) | 2.06085035 |
| 119 | Neonatal onset (HP:0003623) | 2.05466409 |
| 120 | Uterine leiomyosarcoma (HP:0002891) | 2.05060403 |
| 121 | Leiomyosarcoma (HP:0100243) | 2.05060403 |
| 122 | Anal atresia (HP:0002023) | 2.02644380 |
| 123 | Bronchiectasis (HP:0002110) | 2.00367325 |
| 124 | Broad thumb (HP:0011304) | 1.95981305 |
| 125 | Abnormality of complement system (HP:0005339) | 1.95238450 |
| 126 | Tetraparesis (HP:0002273) | 1.94672478 |
| 127 | Febrile seizures (HP:0002373) | 1.94282239 |
| 128 | Absent thumb (HP:0009777) | 1.94133695 |
| 129 | Delayed CNS myelination (HP:0002188) | 1.94100828 |
| 130 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93692639 |
| 131 | Skin nodule (HP:0200036) | 1.93142164 |
| 132 | Enlarged kidneys (HP:0000105) | 1.92957655 |
| 133 | Cone-rod dystrophy (HP:0000548) | 1.92627990 |
| 134 | Neonatal death (HP:0003811) | 1.91019695 |
| 135 | Tubulointerstitial abnormality (HP:0001969) | 1.83784069 |
| 136 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83375601 |
| 137 | Abnormality of dentin (HP:0010299) | 1.83096409 |
| 138 | Infantile muscular hypotonia (HP:0008947) | 1.82493011 |
| 139 | Abnormality of cochlea (HP:0000375) | 1.81977543 |
| 140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.81798146 |
| 141 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.81698437 |
| 142 | Dialeptic seizures (HP:0011146) | 1.81556252 |
| 143 | Renal cell carcinoma (HP:0005584) | 1.80976595 |
| 144 | Turricephaly (HP:0000262) | 1.80721941 |
| 145 | Pterygium (HP:0001059) | 1.80138637 |
| 146 | Status epilepticus (HP:0002133) | 1.79726202 |
| 147 | Pancreatic fibrosis (HP:0100732) | 1.78803925 |
| 148 | Myocardial infarction (HP:0001658) | 1.78063406 |
| 149 | Retinal atrophy (HP:0001105) | 1.77457511 |
| 150 | Joint hemorrhage (HP:0005261) | 1.77426159 |
| 151 | Long toe (HP:0010511) | 1.76767838 |
| 152 | Short 1st metacarpal (HP:0010034) | 1.76765544 |
| 153 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.76765544 |
| 154 | Severe visual impairment (HP:0001141) | 1.76641576 |
| 155 | Lymphangioma (HP:0100764) | 1.76230197 |
| 156 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75404876 |
| 157 | Absent/shortened dynein arms (HP:0200106) | 1.75404876 |
| 158 | Abnormal urine output (HP:0012590) | 1.74972078 |
| 159 | Potter facies (HP:0002009) | 1.74829010 |
| 160 | Facial shape deformation (HP:0011334) | 1.74829010 |
| 161 | Congenital hip dislocation (HP:0001374) | 1.74770531 |
| 162 | Renal cortical cysts (HP:0000803) | 1.74325941 |
| 163 | Spastic diplegia (HP:0001264) | 1.73555647 |
| 164 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73539487 |
| 165 | Pachygyria (HP:0001302) | 1.73321404 |
| 166 | Obstructive sleep apnea (HP:0002870) | 1.72868832 |
| 167 | Mitral stenosis (HP:0001718) | 1.71535170 |
| 168 | Tubulointerstitial fibrosis (HP:0005576) | 1.70218395 |
| 169 | Abnormality of methionine metabolism (HP:0010901) | 1.68416404 |
| 170 | Malnutrition (HP:0004395) | 1.68163578 |
| 171 | Peritonitis (HP:0002586) | 1.67278330 |
| 172 | Alkalosis (HP:0001948) | 1.67144437 |
| 173 | Overgrowth (HP:0001548) | 1.65721870 |
| 174 | Tubulointerstitial nephritis (HP:0001970) | 1.65048812 |
| 175 | Increased CSF protein (HP:0002922) | 1.62142081 |
| 176 | Neonatal short-limb short stature (HP:0008921) | 1.59614146 |
| 177 | Vitreoretinal degeneration (HP:0000655) | 1.58767058 |
| 178 | Broad metatarsal (HP:0001783) | 1.58359103 |
| 179 | Congenital glaucoma (HP:0001087) | 1.57470849 |
| 180 | Glomerulosclerosis (HP:0000096) | 1.56056556 |
| 181 | Abnormal tarsal ossification (HP:0008369) | 1.55565090 |
| 182 | Hepatoblastoma (HP:0002884) | 1.55546903 |
| 183 | Choroideremia (HP:0001139) | 1.54644193 |
| 184 | Chronic hepatic failure (HP:0100626) | 1.54109572 |
| 185 | Esophageal varix (HP:0002040) | 1.53887566 |
| 186 | Late onset (HP:0003584) | 1.53822168 |
| 187 | Metabolic acidosis (HP:0001942) | 1.52507562 |
| 188 | Dysostosis multiplex (HP:0000943) | 1.52408963 |
| 189 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.52349302 |
| 190 | Blue sclerae (HP:0000592) | 1.50999363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 8.04648896 |
| 2 | PINK1 | 4.42093052 |
| 3 | CCNB1 | 4.08908799 |
| 4 | TRIB3 | 3.37629880 |
| 5 | EEF2K | 3.26598359 |
| 6 | FRK | 3.16221692 |
| 7 | BCKDK | 3.09971978 |
| 8 | MAP3K2 | 2.64112928 |
| 9 | SIK1 | 2.58747733 |
| 10 | ZAK | 2.37498560 |
| 11 | MAPKAPK3 | 2.27065521 |
| 12 | ERN1 | 2.21569168 |
| 13 | LATS2 | 2.18426426 |
| 14 | JAK3 | 2.12880373 |
| 15 | ILK | 2.03894651 |
| 16 | WNK4 | 2.00360413 |
| 17 | LATS1 | 1.95909316 |
| 18 | PKN2 | 1.94469329 |
| 19 | FER | 1.88390456 |
| 20 | DDR2 | 1.82969311 |
| 21 | PDGFRA | 1.79493215 |
| 22 | PAK3 | 1.74208852 |
| 23 | PTK2 | 1.71988219 |
| 24 | CAMK1 | 1.70296377 |
| 25 | NTRK2 | 1.69855627 |
| 26 | MAP2K4 | 1.63113796 |
| 27 | CAMK4 | 1.61885224 |
| 28 | IRAK2 | 1.60607766 |
| 29 | CAMKK1 | 1.55945464 |
| 30 | GRK1 | 1.54946868 |
| 31 | RIPK1 | 1.50943498 |
| 32 | PRKD3 | 1.43820415 |
| 33 | NTRK1 | 1.41188520 |
| 34 | CAMK1G | 1.40996374 |
| 35 | PTK6 | 1.38901232 |
| 36 | MST1R | 1.32816448 |
| 37 | MINK1 | 1.31578523 |
| 38 | MAPK12 | 1.31058377 |
| 39 | CAMK1D | 1.30854173 |
| 40 | FGFR2 | 1.30830914 |
| 41 | INSRR | 1.30225077 |
| 42 | TNIK | 1.26920464 |
| 43 | MAP3K4 | 1.25268223 |
| 44 | PNCK | 1.23663908 |
| 45 | PRKCQ | 1.23494194 |
| 46 | TRPM7 | 1.22298791 |
| 47 | MAPK15 | 1.20402146 |
| 48 | DAPK2 | 1.18210638 |
| 49 | MAP2K1 | 1.16355559 |
| 50 | RPS6KA6 | 1.14493209 |
| 51 | MAPK13 | 1.11843340 |
| 52 | RPS6KC1 | 1.11329818 |
| 53 | RPS6KL1 | 1.11329818 |
| 54 | CAMKK2 | 1.11033278 |
| 55 | ERBB4 | 1.06479878 |
| 56 | CHEK2 | 1.04737515 |
| 57 | BMX | 1.03508450 |
| 58 | MAPKAPK5 | 1.03507328 |
| 59 | NTRK3 | 1.01831211 |
| 60 | PAK6 | 1.00098490 |
| 61 | PRKCG | 0.99299497 |
| 62 | STK38 | 0.98599169 |
| 63 | PIK3CA | 0.98358975 |
| 64 | PRKCH | 0.96879418 |
| 65 | RET | 0.95748268 |
| 66 | CASK | 0.95718816 |
| 67 | PAK2 | 0.92413989 |
| 68 | MAPK7 | 0.91699163 |
| 69 | MAP3K3 | 0.91681188 |
| 70 | IRAK1 | 0.91018294 |
| 71 | WNK3 | 0.87032963 |
| 72 | NEK6 | 0.86030630 |
| 73 | MET | 0.85781572 |
| 74 | FGFR4 | 0.82013459 |
| 75 | ERBB3 | 0.80983171 |
| 76 | KSR2 | 0.80635886 |
| 77 | TTN | 0.79750583 |
| 78 | PIK3CG | 0.77125456 |
| 79 | LMTK2 | 0.76883206 |
| 80 | PRKCZ | 0.75410436 |
| 81 | ERBB2 | 0.74919632 |
| 82 | ROCK1 | 0.74276187 |
| 83 | CDC7 | 0.73952648 |
| 84 | NEK9 | 0.73670011 |
| 85 | EPHB2 | 0.73401287 |
| 86 | STK38L | 0.72947712 |
| 87 | PRKCE | 0.72698606 |
| 88 | WNK1 | 0.72097805 |
| 89 | PDGFRB | 0.70765401 |
| 90 | EPHA2 | 0.69917606 |
| 91 | MARK1 | 0.69630824 |
| 92 | PHKG2 | 0.68525544 |
| 93 | PHKG1 | 0.68525544 |
| 94 | CDK6 | 0.68050501 |
| 95 | MAP3K9 | 0.67757318 |
| 96 | IRAK3 | 0.67613599 |
| 97 | NEK1 | 0.67139362 |
| 98 | CAMK2G | 0.66702848 |
| 99 | TTK | 0.65817806 |
| 100 | ACVR1B | 0.65069406 |
| 101 | LRRK2 | 0.64777108 |
| 102 | BMPR1B | 0.64293339 |
| 103 | DYRK1B | 0.64014078 |
| 104 | CSNK1G2 | 0.63138057 |
| 105 | EPHA4 | 0.62865623 |
| 106 | MAP2K2 | 0.62464138 |
| 107 | ADRBK1 | 0.61563815 |
| 108 | PTK2B | 0.60754373 |
| 109 | SGK494 | 0.60518778 |
| 110 | SGK223 | 0.60518778 |
| 111 | RPS6KA2 | 0.59395869 |
| 112 | MAP2K7 | 0.58864862 |
| 113 | GSK3A | 0.58426806 |
| 114 | OXSR1 | 0.57887751 |
| 115 | SCYL2 | 0.57035653 |
| 116 | GRK5 | 0.55356581 |
| 117 | CAMK2D | 0.54365027 |
| 118 | RPS6KB2 | 0.54291784 |
| 119 | MAP4K2 | 0.52265012 |
| 120 | TNK2 | 0.51965298 |
| 121 | IGF1R | 0.51401176 |
| 122 | BCR | 0.50639034 |
| 123 | PDK2 | 0.50389842 |
| 124 | PDPK1 | 0.50261860 |
| 125 | PLK2 | 0.49541833 |
| 126 | MTOR | 0.48626412 |
| 127 | ABL2 | 0.48002873 |
| 128 | STK39 | 0.46614216 |
| 129 | LIMK1 | 0.46440777 |
| 130 | FGFR1 | 0.46203939 |
| 131 | SGK2 | 0.46199181 |
| 132 | CAMK2A | 0.41041011 |
| 133 | CDK9 | 0.35793838 |
| 134 | CSNK1G3 | 0.35503178 |
| 135 | ADRBK2 | 0.32636871 |
| 136 | CSNK1G1 | 0.31383106 |
| 137 | CDK5 | 0.27492583 |
| 138 | PASK | 0.26329883 |
| 139 | EGFR | 0.23559946 |
| 140 | PRKACA | 0.23175359 |
| 141 | PRKACG | 0.22271008 |
| 142 | DYRK3 | 0.21563083 |
| 143 | YES1 | 0.21239669 |
| 144 | CSNK1A1L | 0.21100254 |
| 145 | PRKAA1 | 0.20302146 |
| 146 | OBSCN | 0.20207183 |
| 147 | STK4 | 0.20028346 |
| 148 | PRKCA | 0.18021386 |
| 149 | SRPK1 | 0.16869368 |
| 150 | RPS6KB1 | 0.16638676 |
| 151 | PRKG1 | 0.15450730 |
| 152 | PRKAA2 | 0.15343634 |
| 153 | SGK1 | 0.14478136 |
| 154 | MELK | 0.12900278 |
| 155 | MAPK9 | 0.12895715 |
| 156 | PRKCD | 0.12074121 |
| 157 | WEE1 | 0.09929563 |
| 158 | EIF2AK2 | 0.06379494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33046170 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18710846 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75964880 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.66993210 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.43082543 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.27031175 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24620078 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22751056 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09644621 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06103674 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01444059 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01432825 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97252893 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87459634 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79396004 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79263951 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.78163529 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.75127274 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72472205 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64110319 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63165519 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58448302 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58413879 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56016457 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.52896228 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51477183 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50992983 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.46041087 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.45412589 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45290760 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42182707 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.41158372 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34197343 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31721299 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31014155 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.30439276 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26907604 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24863528 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21388137 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21132176 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.19240261 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18539088 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16804488 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14629067 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14384741 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09364579 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07846647 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07461907 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07185952 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05616914 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05519484 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05185539 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04559970 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04535264 |
| 55 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.04315056 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01413966 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.99980412 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99492608 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96781194 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 0.96272131 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95924014 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94867584 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93216806 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92685798 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90858590 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90076997 |
| 67 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88406108 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87064120 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83865820 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83804471 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83403047 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81863088 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80851971 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79866478 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.79455762 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77660971 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.77518961 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76696507 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75561797 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74275340 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72814720 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72412892 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70725609 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69785438 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68534976 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67893598 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67052841 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65916563 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.65566580 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.63529323 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63376322 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62803462 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61101290 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58798059 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57782760 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56208592 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54693054 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53679173 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51964787 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51700010 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51379535 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50881579 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49341426 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48148666 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47801265 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47579817 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47009959 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45665728 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45470946 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45035064 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44927928 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43317480 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41343506 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.40260919 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39862745 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39224058 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38550974 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38072574 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37049925 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.36999761 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34504931 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33348588 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30776926 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30246751 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29540138 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29536813 |
| 127 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29357475 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28578773 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.27531906 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.26457641 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25702267 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.22475568 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.22384833 |
| 134 | Gap junction_Homo sapiens_hsa04540 | 0.20579378 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20502793 |
| 136 | Salivary secretion_Homo sapiens_hsa04970 | 0.19671171 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.19354593 |
| 138 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.19351944 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18756341 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.17960504 |

